Presentation Information
[MSY4-4]Tau PET perspectives on optimizing amyloid-targeted therapy and remaining challenges
Hitoshi Shimada1,2 (1.Department of Functional Neurology & Neurosurgery, Center for Integrated Human Brain Science, Brain Research Institute, Niigata University、2.Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology)